Viehweger et al. Estrogen receptor expression in human tumors: A tissue microarray study evaluating more than 18,000 tumors from 149 different entities. Hum Pathol. 2025 Mar 5;157:105757. doi: 10.1016/j.humpath.2025.105757. Epub ahead of print. PMID: 40054585.

 

 

 


Estrogen Receptor clone (MSVA-564R):

Estrogen receptor expression in human tumors: A tissue microarray study evaluating more than 18,000 tumors from 149 different entities

 

Estrogen Receptor clone MSVA-564R

 

 

 

 

 

 

 

 

 

Jansen et al. Carcinoembryonic Antigen Expression in Human Tumors: A Tissue Microarray Study on 13,725 Tumors. Cancers (Basel). 2024 Dec 3;16(23):4052. doi: 10.3390/cancers16234052. PMID: 39682238; PMCID: PMC11640007.

 

 

 


CEA / CEACAM5 / CD66e clone (MSVA-465R):

Carcinoembryonic Antigen Expression in Human Tumors: A Tissue Microarray Study on 13,725 Tumors

 

CEA clone MSVA-465R

 

 

 

 

 

 

 

 

 

Lutz et al. PAX6 is a useful marker for pancreatic origin of neuroendocrine neoplasms: A tissue microarray study evaluating more than 19,000 tumors from 150 different tumor types. Hum Pathol. 2024 Dec;154:105695. doi: 10.1016/j.humpath.2024.105695. Epub 2024 Nov 19. PMID: 39571690.

 

 

 


PAX6 clone (MSVA-706M):

PAX6 is a useful marker for pancreatic origin of neuroendocrine neoplasms: A tissue microarray study evaluating more than 19,000 tumors from 150 different tumor types

 

PAX6 clone MSVA-706M

 

 

 

 

 

 

 

 

 

Furlano et al Reduced p63 expression is linked to unfavourable prognosis in muscle-invasive urothelial carcinoma of the bladder. BJUI Compass. 2024 Sep 10;5(11):1081-1089. doi: 10.1002/bco2.431. Erratum in: BJUI Compass. 2024 Dec 30;5(12):1324-1329. doi: 10.1002/bco2.482. PMID: 39539567; PMCID: PMC11557268.

 

 

 


p63 clone (MSVA-063R):

Reduced p63 expression is linked to unfavourable prognosis in muscle-invasive urothelial carcinoma of the bladder

 

p63 clone MSVA-063R

 

 

 

 

 

 

 

 

 

 

Gorbokon et al. Prevalence of S-methyl-5′-thioadenosine Phosphorylase (MTAP) Deficiency in Human Cancer: A Tissue Microarray Study on 13,067 Tumors From 149 Different Tumor Types. Am J Surg Pathol. 2024 Oct 1;48(10):1245-1258. doi: 10.1097/PAS.0000000000002297. Epub 2024 Aug 12. PMID: 39132873

 

 

 


MTAP clone (MSVA-741R):

Prevelance of S-methyl-5thioadenosine Phosphorylase (MTAP) Deficiency in Human Cancer: A Tissue Microarray Study on 13,067 Tumors from 149 Different Tumor Types

 

MTAP clone MSVA-741R

 

 

 

 

 

 

 

 

 

Scherzai et al. PGP9.5 expression in human tumors: A tissue microarray study on 13,920 tumors from 120 different tumor entities. Pathol Res Pract. 2024 Oct 28;264:155676. doi: 10.1016/j.prp.2024.155676. Epub ahead of print. PMID: 39520970.

 

 

 


PGP9.5 clone (MSVA-905R):

PGP9.5 expression in human tumors: A tissue microarray study on 13,920 tumors from 120 different tumor entities 

 

PGP9.5 clone MSVA-905R

 

 

 

 

 

 

 

 

Lutz et al. Expression of Trefoil Factor 1 (TFF1) in Cancer: A Tissue Microarray Study Involving 18,878 Tumors. Diagnostics (Basel). 2024 Sep 28;14(19):2157. doi: 10.3390/diagnostics14192157. PMID: 39410561; PMCID: PMC11475926.

 

 

 


TFF1 clone (MSVA-482M):

Expression of Trefoil Factor 1 (TFF1) in Cancer: A Tissue Microarray Study Involving 18,878 Tumors

 

TFF1 clone MSVA-482M

 

 

 

 

 

 

 

 

Möller et al. TTF-1 is a highly sensitive but not fully specific marker for pulmonary and thyroidal cancer: a tissue microarray study evaluating more than 17,000 tumors from 152 different tumor entities. Virchows Arch. 2024 Nov;485(5):815-828. doi: 10.1007/s00428-024-03926-1. Epub 2024 Oct 8. PMID: 39377914; PMCID: PMC11564378.

 

 

 


TTF-1 clone (MSVA-312R):

TTF-1 is a highly sensitive but not fully specific marker for pulmonary and thyroidal cancer: a tissue microarray study evaluating more than 17,000 tumors from 152 different tumor entities

 

TTF-1 clone MSVA-312R

 

 

 

 

 

 

 

 

 

Lennartz et al. GAD2 Is a Highly Specific Marker for Neuroendocrine Neoplasms of the Pancreas. Am J Surg Pathol. 2024 Jan 25. doi: 10.1097/PAS.0000000000002186. Epub ahead of print. PMID: 38271200.

 

 

 


GAD2 clone (MSVA-602M):

GAD2 Is a Highly Specific Marker for Neuroendocrine Neoplasms of the Pancreas

 

GAD2 clone MSVA-602M

 

 

 

 

 

 

 

 

 

Möller et al. Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumors. Mol Cell Endocrinol. 2024 Feb 1;581:112106. doi: 10.1016/j.mce.2023.112106. Epub 2023 Nov 10. PMID: 37951531.

 

 

 


INSM1 clone (MSVA-456R):

Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumors

 

INSM1 clone MSVA-456R

 

 

 

 

 

 

 

 

 

Viehweger et al. Prostein expression in human tumors: a tissue microarray study on 19,202 tumors from 152 different Tumor entities. Diagn Pathol. 2024 Jan 13;19(1):12. doi: 10.1186/s13000-023-01434-5. PMID: 38218896; PMCID: PMC10788021.

 

 

 


Prostein clone (MSVA-460R):

Prostein expression in human tumors: a tissue microarray study on 19,202 tumors from 152 different Tumor entities

 

Prostein clone MSVA-460R

 

 

 

 

 

 

 

 

 

Tribian et al. Diagnostic Role and Prognostic Impact of PSAP Immunohistochemistry: A Tissue Microarray Study on 31,358 Cancer Tissues. Diagnostics (Basel). 2023 Oct 18;13(20):3242. doi: 10.3390/diagnostics13203242. PMID: 37892063; PMCID: PMC10606209.

 

 

 


PSAP clone (MSVA-452M):

Diagnostic Role and Prognostic Impact of PSAP Immunohistochemistry: A Tissue Microarray Study on 31,358 Cancer Tissues

 

PSAP clone MSVA-452M

 

 

 

 

 

 

 

 

 

Kaczmarek et al. Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladder. Int Urol Nephrol. 2024 Feb;56(2):499-508. doi: 10.1007/s11255-023-03800-0. Epub 2023 Oct 1. PMID: 37777995; PMCID: PMC10808463.

 

 

 


Uroplakin 1A (MSVA-735M) & Uroplakin 1B (MSVA-734M):

Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladder

 

Uroplakin 1A clone MSVA-735MUroplakin 1B clone MSVA-734M

 

 

 

 

 

 

 

 

Lennartz et al. Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid. Sci Rep. 2023 Aug 9;13(1):12917. doi: 10.1038/s41598-023-39945-2. PMID: 37558687; PMCID: PMC10412623.

 

 

 


Cadherin-16 clone (MSVA-516R):

Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid.

 

Cadherin-16 clone MSVA-516R

 

 

 

 

 

 

 

 

Reiswich et al.GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors. Published in Pathobiology. 2023 Jan 17:1-14. doi: 10.1159/000527382. Epub ahead of print. PMID: 36649695.

 

 

 


GATA3 clone (MSVA-450M):

GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors

 

GATA3 clone MSVA-450M

 

 

 

 

 

 

 

 

 

Viehweger et al. Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumors. Pathol Res Pract. 2022 Nov 5;240:154200. doi: 10.1016/j.prp.2022.154200. Epub ahead of print. PMID: 36375372.

 

 

 


Desmoglein 3 clone (MSVA-543M):

Desmoglein 3 (Dsg3) expression in cancer – A tissue microarray study on 15,869 tumors

 

Desmoglein 3 clone MSVA-543M

 

 

 

 

 

 

 

 

Weidemann et al. Inhibin Alpha Expression in Human Tumors: A Tissue Microarray Study on 12,212 Tumors. Biomedicines. 2022 Oct 7;10(10):2507. doi: 10.3390/biomedicines10102507. PMID: 36289769; PMCID: PMC9598868.

 

 

 


Inhibin Alpha clone (MSVA-561R):

Inhibin Alpha Expression in Human Tumors – A Tissue Microarray Study on 12,212 Tumors

 

Inhibin alpha clone MSVA-561R

 

 

 

 

 

 

 

 

Lennartz et al. Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10,439 tumors. APMIS. 2022 Oct 21. doi: 10.1111/apm.13280. Epub ahead of print. PMID: 36269681.

 

 

 

 


Cytokeratin 13 clone (MSVA-613M):

Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10,439 tumors

 

Cytokeratin 13 clone MSVA-613M

 

 

 

 

 

 

 

 

Lennartz et al. Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial Cells. Diagnostics (Basel). 2022 Oct 17;12(10):2516. doi: 10.3390/diagnostics12102516. PMID: 36292206; PMCID: PMC9600073.

 

 

 


Uroplakin 3B clone (MSVA-736M):

Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial Cells.

 

Uroplakin 3B clone MSVA-736M

 

 

 

 

 

 

 

 

 

Uhlig et al. Diagnostic and prognostic role of pancreatic secretory granule membrane major glycoprotein 2 (GP2) immunohistochemistry: A TMA study on 27,681 tumors. Pathol Res Pract. 2022 Sep 15;238:154123. Epub ahead of print. PMID: 36137400.

 

 

 


GP2 clone (MSVA-475M):

Diagnostic and prognostic role of pancreatic secretory granule membrane major glycoprotein 2 (GP2) immunohistochemistry: A TMA study on 27,681 tumors

 

GP2 clone MSVA-475M

 

 

 

 

 

 

 

 

Uhlig et al. Cytokeratin 10 (CK10) expression in cancer: A tissue microarray study on 11,021 tumors. Ann Diagn Pathol. 2022 Aug 20;60:152029. Epub ahead of print. PMID: 36029589.

 

 

 


Cytokeratin 10 clone (MSVA-610M):

Cytokeratin 10 expression in cancer: A tissue microarray study on 11,021 tumors

 

Cytokeratin 10 clone MSVA-610M

 

 

 

 

 

 

 

 

Viehweger et al. Diagnostic and Prognostic Impact of Progesterone Receptor Immunohistochemistry: A Study Evaluating More Than 16,000 Tumors. Anal Cell Pathol (Amst). 2022 Aug 8;2022:6412148. PMID: 35992051

 

 

 

Progesterone Receptor clone (MSVA-570R):

Diagnostic and Prognostic Impact of Progesterone Receptor Immunohistochemistry: A Study Evaluating More Than 16,000 Tumors

 

Progesterone Receptor clone MSVA-570R

 

 

 

 

 

 

 

 

 

Dum et al. “FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors.” Virchows Arch. 2022 Aug 11. doi: 10.1007/s00428-022-03394-5. Epub ahead of print. PMID: 35951102.

 

 

 

 

FABP1 antibody clone (MSVA-501M):

FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors.

 

FABP1 clone MSVA-501M

 

 

 

 

 

 

 

 

Menz et al. “Pan-keratin Immunostaining in Human Tumors: A Tissue Microarray Study of 15,940 Tumors.” Int J Surg Pathol. 2022 Aug 9:10668969221117243. doi: 10.1177/10668969221117243. Epub ahead of print. PMID: 35946088.

 

 

 

 

Pan Cytokeratin antibody clone (MSVA-000R):

Pan-keratin Immunostaining in Human Tumors: A Tissue Microarray Study of 15,940 Tumors

 

Pan Cytokeratin clone MSVA-000R

 

 

 

 

 

 

 

 

Uhlig et al. “Synaptophysin and chromogranin A expression analysis in human tumors.” Mol Cell Endocrinol. 2022 Jul 31;555:111726. doi: 10.1016/j.mce.2022.111726. Epub ahead of print. PMID: 35921917.

 

 

 


Synaptophysin (MSVA-462R) & Chromogranin A (MSVA-380R):

Synaptophysin and chromogranin A expression analysis in human tumors.

 

Synaptophysin clone MSVA-462RChromogranin A clone MSVA-380R

 

 

 

 

 

 

 

 

Dum et al. SATB2 Expression in Human Tumors. Arch Pathol Lab Med. 2022 Aug 2. doi: 10.5858/arpa.2021-0317-OA. Epub ahead of print. PMID: 35917493.

 

 

 

 

SATB2 antibody clone (MSVA-702R):

SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15.000 Tumors

 

SATB2 clone MSVA-702R

 

 

 

 

 

 

 

Reiswich et al. Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancer. Published in Pathology Research and Practice 2022 Jul 18;237:154028. doi: 10.1016/j.prp.2022.154028. Epub ahead of print. PMID: 35872365.

 

 

 

 

Uroplakin 1A antibody clone MSVA-735M:

Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancer.

 

Uroplakin 1A clone MSVA-735M

 

 

 

 

 

 

 

 

Dum et al. “Villin expression in human tumours: a tissue microarray study on 14,398 tumours.” Expert Rev Mol Diagn. 2022 Jul 22. doi: 10.1080/14737159.2022.2104122. Epub ahead of print. PMID: 35866621.

 

 

 

 

Villin antibody clone (MSVA-459R):

Villin expression in human tumours: a tissue microarray study on 14,398 tumours

 

Villin clone MSVA-459R

 

 

 

 

 

 

 

 

De Wispelaere et al. High prevalence of p16 staining in malignant tumors. PLoS One. 2022 Jul 21;17(7):e0262877. doi: 10.1371/journal.pone.0262877. PMID: 35862385;

 

 

 

 

p16 antibody clone (MSVA-016R):

High prevalence of p16 staining in malignant tumors

 

p16 clone MSVA-016R

 

 

 

 

 

 

 

Reiswich et al. „Large-scale human tissue analysis identifies Uroplakin 1b as a putative diagnostic marker in surgical pathology. “Published in Human Pathology. 2022 May 10;126:108-120. PMID: 35550834.

 

 

 

 

Uroplakin 1B antibody clone MSVA-734M:

Large-scale human tissue analysis identifies Uroplakin 1b as a putative diagnostic marker in surgical pathology.

 

Uroplakin 1B clone MSVA-734M

 

 

 

 

 

 

 

 

Dum et al. “Trophoblast cell surface antigen 2 (TROP2) expression in human tumors: A tissue microarray study on 18,563 tumors.” Published in Pathobiology. 2022 Apr 27:1-14. PMID: 35477165.

 

 

 

 

TACSTD2 / Trop-2 (MSVA-733R) :

Trophoblast cell surface antigen 2 (TROP2) expression in human tumors: A tissue microarray study on 18,563 tumors.

 

TACSTD2 / Trop2 clone MSVA-733R

 

 

 

 

 

 

 

 

Dum et al. “ Dum et al. Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers. Exp Mol Pathol. 2022 Apr 4;126:104762. doi: PMID: 35390310.

 

 

 

 

Cytokeratin 7 (MSVA-607R) & Cytokeratin 20 (MSVA-620R):

Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers

 

Cytokeratin 7 clone MSVA-607RCytokeratin 20 clone MSVA-620R

 

 

 

 

 

 

 

 

Dum et al. Semi-automated validation and quantification of CTLA-4 in 90 different tumor entities using multiple antibodies and artificial intelligence. Lab Invest. 2022 Jan 29. PMID: 35091676.

 

 

 

 

 

CTLA-4 antibody clone MSVA-152R

Semi-automated validation and quantification of CTLA-4 in 90 different tumor entities using multiple antibodies and artificial intelligence.

 

CTLA-4 clone MSVA-152R

 

 

 

 

 

 

 

 

 

Meiners et al. Biomedicines. 2021 Dec 3;9(12):1831. PMID: 34944647

 

 

 

 

ACE2 antibody clone MSVA-919R:

Angiotensin-Converting Enzyme 2 Protein Is Overexpressed in a Wide Range of Human Tumour Types: A Systematic Tissue Microarray Study on >15,000 Tumours.

 

ACE2 clone MSVA-919R

 

 

 

 

 

 

 

 

 

Uhlig R et al. Am J Surg Pathol. 2022 Jan 1;46(1):97-104. PMID: 34889867.

 

 

 

 

CPA1 antibody clone MSVA-601M:

Carboxypeptidase A1 (CPA1) Immunohistochemistry Is Highly Sensitive and Specific for Acinar Cell Carcinoma (ACC) of the Pancreas

 

CPA1 clone MSVA-601M

 

 

 

 

 

 

 

 

 

Lennartz et al. Diagnostics (Basel) 2021 Dec; 11(12): 2351.

 

 

 

 

Arginase-1 antibody clone MSVA-511R:

Large scale tissue Microarray evaluation corroborates high specificity of high-level Arginase-1 immunostaining for Hepatocellular Carcinoma

 

Arginase-1 clone MSVA-511R

 

 

 

 

 

 

 

 

 

MUC5AC Expression in Various Tumor Types and Nonneoplastic Tissue - A Tissue Microarray Study on 10 399 Tissue Samples
Dwertmann Rico et al: Technology in Cancer Research & Treatment, Published online 2021 September 21th

 

 

 

 

MUC5AC antibody clone MSVA-109M:

MUC5AC Expression in Various Tumor Types and Nonneoplastic Tissue: A Tissue Microarray Study on 10 399 Tissue Samples

 

MUC5AC clone MSVA-109M

 

 

 

 

 

 

 

Dwertmann et al Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinoma. Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221106504. PMID: 35764407

 

 

 

 

 

MUC5AC antibody clone MSVA-109M

Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinoma.

 

MUC5AC clone MSVA-109M

 

 

 

 

 

 

 

Jansen et al. Pathology – Research and Practice Volume 228: December 2021

 

 

 

 

DOG1 antibody clone MSVA-201M:

DOG1 expression is common in human tumors: A tissue microarray study on more than 15,000 tissue samples

 

DOG1 clone MSVA-201M

 

 

 

 

 

 

 

 

 

 

 

 

Weidemann et al. Biomedicines 2021, 9, 397.

 

 

 

 

Mesothelin antibody clone MSVA-235M:

Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors Biomedicines 2021 published by: Weidemann et al.

 

Mesothelin clone MSVA-235M

 

 

 

 

 

 

 

 

 

Steurer et al. Annals of Diagnostic Pathology, Volume 54, October 2021, 151793

 

 

 

 

Thyroglobulin antibody clone MSVA-189R:

Immunohistochemically detectable thyroglobulin expression in extrathyroidal cancer is 100% specific for thyroidal tumor origin.

 

Thyroglobulin clone MSVA-189R

 

 

 

 

 

 

 

 

 

Menz et al. Molecular Medicine 27, Article number: 16 (2021)

 

 

 

 

Cytokeratin 18 antibody clone MSVA-118R:

Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: A tissue microarray study on 11,952 tumors

 

Cytokeratin 18 clone MSVA-118R

 

 

 

 

 

 

 

 

 

Reiswich et al. The journal of Pathology: Clinical Research, August 7th 2021

 

 

 

 

PLAP antibody clone MSVA-350R:

Pattern of placental alkaline phosphatase (PLAP) expression in human tumors: a tissue microarray study on 12,381 tumors

 

PLAP clone MSVA-350R

 

 

 

 

 

 

 

 

 

 

Merz et al. Human Pathology: Volume 115, September 2021

 

 

 

 

Cytokeratin 19 antibody clone MSVA-119M:

Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors

 

Cytokeratin 19 clone MSVA-119M

 

 

 

 

 

 

 

 

 

Weidemann et al. Pathology & Oncology Research 2021; 27: 613099

 

 

 

 

Napsin A antibody clone MSVA-112R:

Napsin A Expression in Human Tumors and Normal Tissues

 

Napsin A clone MSVA-112R

 

 

 

 

 

 

 

 

 

Völkel et al. Virchow Archiv published online; September 24th 2021

 

 

 

 

Cytokeratin 5 (MSVA-605M) & Cytokeratin 6 (MSVA-606R):

Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications

 

Cytokeratin 5 clone MSVA-605MCytokeratin 6 clone MSVA-606R

 

 

 

 

 

 

 

 

 

Möller et al. International Urology and Nephrology (2021) 53:2493-2503

 

 

 

 

 

 

PD-L1 antibody clone MSVA-711R (clone# changed from MSVA-011):

Tumor cell PD‐L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy‐naive clear cell renal cell cancer

 

PD-L1 clone MSVA-711R